Bench-to-bedside review: Chloride in critical illness

Critical Care

Volumn 14, Issue 4, 2010, Pages

  Yunos, Nor'azim M ^a   Bellomo, Rinaldo ^a   Story, David ^a   Kellum, John ^b  

^a AUSTIN HOSPITAL   (Australia)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE; CHLORIDE CHANNEL;

ACID BASE BALANCE; COLLOID; CRITICAL ILLNESS; DIURETIC ACTIVITY; FLUID RESUSCITATION; HEMOSTASIS; HUMAN; HYPERCHLOREMIA; HYPOCHLOREMIA; INTENSIVE CARE UNIT; KIDNEY FUNCTION; MEDICAL PRACTICE; POINT OF CARE TESTING; PRIORITY JOURNAL; REVIEW; SEPSIS; SPLANCHNIC BLOOD FLOW; ANIMAL; BLOOD; FLUID THERAPY; GASTROINTESTINAL TRACT; INTENSIVE CARE; KIDNEY; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACID-BASE EQUILIBRIUM; ANIMALS; CHLORIDE CHANNELS; CHLORIDES; CRITICAL ILLNESS; FLUID THERAPY; GASTROINTESTINAL TRACT; HUMANS; INTENSIVE CARE; KIDNEY; SEPSIS;

EID: 78149464585     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9052     Document Type: Review

References (83)

1. Ganong WF. Review of Medical Physiology 2005, New York: McGraw Hill, 22.
2. PubMed. , http://www.ncbi.nlm.nih.gov/pubmed
3. Kellum JA. Acid-base physiology in the post-Copernican area. Curr Opin Crit Care 1999, 5:429-435.
4. Cushing H. Concerning the poisonous effect of pure sodium chloride solutions upon nerve-muscle preparation. Am J Physiol 1901, 6:77-90.
5. Odaira T. The influence of some neutral salt solutions, intravenously administered, on the reserve alkali of the blood. Tohoku J Exp Med 1923, 4:523-526.
6. Shires GT, Holman J. Dilution acidosis. Ann Intern Med 1948, 28:557-559.
7. Black DAK. Body fluid depletion. Lancet 1953, 261:305-311.
8. McFarlane C, Lee A. A comparison of Plasmalyte 148 and 0.9% saline for intra-operative fluid replacement. Anaesthesia 1994, 49:779-781. 10.1111/j.1365-2044.1994.tb03311.x, 7978133.
9. Scheingraber S, Rehm M, Sehmisch C, Finsterer U. Rapid saline infusion produces hyperchloraemic acidosis in patients undergoing gynecologic surgery. Anesthesiology 1999, 90:1265-1270. 10.1097/00000542-199905000-00007, 10319771.
10. Waters JH, Miller LR, Clack S, Kim JV. Cause of metabolic acidosis in prolonged surgery. Crit Care Med 1999, 27:2142-2146. 10.1097/00003246-199910000-00011, 10548196.
11. Liskaser FJ, Bellomo R, Hayhoe M, Story D, Poustie S, Smith B, Letis A, Bennett M. The role of pump prime in the etiology and pathogenesis of cardiopulmonary bypass-associated acidosis. Anesthesiology 2000, 93:1170-1173. 10.1097/00000542-200011000-00006, 11046201.
12. Rehm M, Orth V, Scheingraber S, Kreimeier U, Brechtelsbauer H, Finsterer U. Acid-base changes due to 5% albumin versus 6% hydroxyethylstarch solution in patients undergoing acute normovolemic hemodilution: a randomized prospective study. Anesthesiology 2000, 93:1174-1183. 10.1097/00000542-200011000-00007, 11046202.
13. Waters JH, Bernstein CA. Dilutional acidosis following hetastarch or albumin in healthy volunteers. Anesthesiology 2000, 93:1184-1187. 10.1097/00000542-200011000-00008, 11046203.
14. Wilkes NJ, Woolf R, Mutch M, Mallett SV, Peachey T, Stephens R, Mythen MG. The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg 2001, 93:811-816. 10.1097/00000539-200110000-00003, 11574338.
15. Waters JH, Gottlieb A, Schoenwald P, Popovic MJ, Sprung J, Nelson DR. Normal saline versus lactated Ringer's solution for intraoperative fluid management in patients undergoing abdominal aortic aneurysm repair: an outcome study. Anesth Analg 2001, 93:817-822. 10.1097/00000539-200110000-00004, 11574339.
16. Stewart PA. How to Understand Acid-Base. A Quantitative Primer for Biology and Medicine 1981, New York: Elsevier.
17. Stewart PA. Modern quantitative acid-base chemistry. Can J Physiol Pharmacol 1983, 61:1444-1461.
18. Klemtz K, Ho L, Bellomo R. Daily intravenous chloride load and the acid-base and biochemical status of intensive care unit patients. J Pharm Pract Res 2008, 38:296-299.
19. Jentsch TJ. Chloride channels are different. Nature 2002, 415:276-277. 10.1038/415276a, 11796992.
20. Dutzler R, Campbell EB, Cadene M, Chait BT, MacKinnon R. X-ray structure of a ClC channel at 3.0 Å reveals the molecular basis of anion selectivity. Nature 2002, 415:287-294. 10.1038/415287a, 11796999.
21. Jentsch TJ, Stein V, Weinreich F, Zdebik AA. Molecular structure and physiological function of chloride channels. Physiol Rev 2002, 82:503-568.
22. Food and Nutrition Board, Institute of Medicine of the National Academies Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate 2004, Washington, DC: National Academies Press, Food and Nutrition Board, Institute of Medicine of the National Academies.
23. Schultz SG. The internal environment. Essential Medical Physiology 2003, 4-6. San Diego: Academic Press, Johnson LR, Byrne JH, 3.
24. Koch SM, Taylor RW. Chloride ion in intensive care medicine. Crit Care Med 1992, 20:227-240. 10.1097/00003246-199202000-00012, 1737457.
25. Morimatsu H, Rocktaschel J, Bellomo R, Uchino S, Goldsmith D, Gutteridge G. Comparison of point-of-care versus central laboratory measurement of electrolyte concentrations on calculations of the anion gap and the strong ion difference. Anesthesiology 2003, 98:1077-1084. 10.1097/00000542-200305000-00009, 12717128.
26. Story D, Morimatsu H, Egi M, Bellomo R. The effect of albumin concentration on plasma sodium and chloride measurements in critically ill patients. Anesth Analg 2007, 104:893-897. 10.1213/01.ane.0000258015.87381.61, 17377102.
27. Figge J, Jabor A, Kazda A, Fencl V. Anion gap and hypoalbuminemia. Crit Care Med 1998, 26:1807-1810.
28. Kellum JA, Kramer DJ, Pinsky MR. Strong ion gap: a methodology for exploring unexplained anions. J Crit Care 1995, 10:51-55. 10.1016/0883-9441(95)90016-0, 7647842.
29. Story D, Morimatsu H, Bellomo R. Strong-ions, weak-acids, and base-excess: a simplified Fencl-Stewart approach to clinical acid-base disorders. Br J Anaesth 2004, 92:54-60. 10.1093/bja/aeh018, 14665553.
30. Boldt J, Schollhorn T, Munchbach J, Pabsdorf M. A total balanced volume replacement strategy using a new balanced hydroxyethyl starch preparation (6% HES 130/0.42) in patients undergoing major abdominal surgery. Eur J Anaesthesiol 2007, 24:267-275. 10.1017/S0265021506001682, 17054812.
31. Story DA, Morimatsu H, Bellomo R. Hyperchloraemic acidosis in the critically ill: one of the strong-ion acidoses?. Anesth Analg 2006, 103:144-148. 10.1213/01.ane.0000221449.67354.52, 16790643.
32. Rocktaeschel J, Morimatsu H, Uchino S, Bellomo R. Unmeasured anions in critically ill patients: can they predict mortality?. Crit Care Med 2003, 31:2131-2136. 10.1097/01.CCM.0000079819.27515.8E, 12973170.
33. Antinoni B, Piva S, Paltenghi M, Candiani A, Latronico N. The early phase of critical illness is a progressive acidic state due to unmeasured anions. Eur J Anaesthesiol 2008, 25:566-572. 10.1017/S0265021508003669, 18339216.
34. Story DA. Hyperchloraemic acidosis: another misnomer?. Crit Care Resusc 2004, 6:188-192.
35. Alfaro V, Torras R, Ibanez J, Palacios L. A physical-chemical analysis of the acid-base response to chronic obstructive pulmonary disease. Can J Physiol Pharmacol 1996, 74:1229-1235. 10.1139/cjpp-74-11-1229, 9028582.
36. Levitin H, Branscome W, Epstein FH. The pathogenesis of hypochloremia in respiratory acidosis. J Clin Invest 1958, 37:1667-1675. 1062852, 13611033, 10.1172/JCI103758.
37. Verkman AS, Galietta JV. Chloride channels as drug targets. Nat Rev Drug Discov 2009, 8:153-171. 10.1038/nrd2780, 19153558.
38. Pusch M. Myotonia caused by mutations in the muscle chloride channel gene CLCN1. Hum Mut 2002, 19:423-434. 10.1002/humu.10063, 11933197.
39. Haug K, Warnstedt M, Alekov AK, Sander T, Ramirez A, Poser B, Maljevic S, Hebeisen S, Kubisch C, Rebstock J, Horvath S, Hallman K, Dullinger JS, Rau B, Haverkamp F, Beyenburg S, Schulz H, Janz D, Giese B, Müller-Newen G, Propping P, Elger CE, Fahlke C, Lerche H, Heils A. Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies. Nat Genet 2003, 33:527-532. 10.1038/ng1121, 12612585.
40. Crowell MD, Harris LA, DiBaise JK, Olden KW. Activation of type-2 chloride channels: a novel therapeutic target for the treatment of chronic constipation. Curr Opin Investig Drugs 2007, 8:66-70.
41. Okada Y, Shimizu T, Maeno E, Tanabe S, Wang X, Takahashi N. Volume-sensitive chloride channels involved in apoptotic volume decrease and cell death. J Membrane Biol 2006, 209:21-29.
42. Pinheiro da Silva F, Nizet V. Cell death during sepsis: integration of disintegration in the inflammatory response to overwhelming infection. Apoptosis 2009, 14:509-521. 10.1007/s10495-009-0320-3, 19199035.
43. Barret KE. Gastrointestinal Physiology 2006, New York: McGraw-Hill.
44. Barret KE, Keely SJ. Chloride secretion by the intestinal epithelium: molecular basis and regulatory aspects. Annu Rev Physiol 2000, 62:535-572. 10.1146/annurev.physiol.62.1.535, 10845102.
45. Guyton AC, Hall JE. Textbook of Medical Physiology 2006, Philadelphia: Elsevier Sanders, 11.
46. Corey HE. Renal acid-base physiology. Critical Care Nephrology 2009, 587-592. Philadelphia: Elsevier Sanders, Ronco C, Bellomo R, Kellum JA, 2.
47. Sindic A, Chang MH, Mount DB, Romero MF. Renal physiology of SLC26 anion exchangers. Curr Opin Nephrol Hypertens 2007, 16:484-490. 10.1097/MNH.0b013e328011cb4a, 17693766.
48. Romero MF. Molecular pathophysiology of SLC4 bicarbonate transporters. Curr Opin Nephrol Hypertens 2005, 14:495-501. 10.1097/01.mnh.0000168333.01831.2c, 16046910.
49. Ring T, Frische S, Nielsen S. Clinical review: renal tubular acidosis - a physicochemical approach. Crit Care 2005, 9:573-580. 1414010, 16356241, 10.1186/cc3802.
50. Kellum JA. Determinants of plasma acid-base balance. Crit Care Clin 2005, 21:329-346. 10.1016/j.ccc.2005.01.010, 15781166.
51. Wakim KG. 'Normal' 0.9% salt solution is neither 'normal' nor physiological [letter]. JAMA 1970, 214:1710. 10.1001/jama.214.9.1710b, 5536543.
52. Reid F, Lobo DN, Williams RN, Rowlands BJ, Allison SP. (Ab)normal saline and physiological Hartmann's solution: a randomized double-blind crossover study. Clin Sci 2003, 104:17-24. 10.1042/CS20020202, 12519083.
53. Latta T. Malignant cholera. Lancet 1832, ii:1831-274.
54. Awad S, Allison SP, Lobo DN. The history of 0.9% saline. Clin Nutr 2008, 27:179-188. 10.1016/j.clnu.2008.01.008, 18313809.
55. Stoneham MD, Hill EL. Variability in post-operative fluid and electrolyte prescription. Br J Clin Pract 1997, 51:82-84.
56. Lobo DN, Dube MG, Neal KR, Simpson JS, Rowlands BJ, Allison SP. Problems with solutions: drowning in the brine of an inadequate knowledge base. Clin Nutr 2001, 20:125-130. 10.1054/clnu.2000.0154, 11327739.
57. Kellum JA, Bellomo R, Kramer DJ, Pinsky MR. Etiology of metabolic acidosis during saline resuscitation in endotoxaemia. Shock 1998, 9:364-368. 10.1097/00024382-199805000-00009, 9617887.
58. Kellum JA. Fluid resuscitation and hyperchloraemic acidosis in experimental sepsis: improved short-term survival and acid-base balance with Hextend compared with saline. Crit Care Med 2002, 30:300-305. 10.1097/00003246-200202000-00006, 11889298.
59. Kellum JA, Song M, Venkataraman R. Effects of hyperchloraemic acidosis on arterial pressure and circulating inflammatory molecules in experimental sepsis. Chest 2004, 125:243-248. 10.1378/chest.125.1.243, 14718447.
60. Kellum JA, Song M, Li J. Lactic and hydrochloric acids induce different patterns of inflammatory response in LPS-stimulated RAW 264.7 cells. Am J Physiol Regul Integr Comp Physiol 2004, 286:R686-R692.
61. Kellum JA, Song M, Almasri E. Hyperchloraemic acidosis increases circulating inflammatory molecules in experimental sepsis. Chest 2006, 130:962-967. 10.1378/chest.130.4.962, 17035425.
62. Kellum JA. Metabolic acidosis in patients with sepsis: epiphenomenon or part of the pathophysiology?. Crit Care Resusc 2004, 6:197-203.
63. Pedoto A, Caruso JE, Nandi J. Acidosis stimulates nitric oxide production and lung damage in rats. Am J Respir Crit Care Med 1999, 159:397-402.
64. Pedoto A, Nandi J, Oler A, Camporesi AM, Hakim TS, Levine RA. Role of nitric oxide in acidosis-induced intestinal injury in anaesthetized rats. J Lab Clin Med 2001, 138:270-276. 10.1067/mlc.2001.118176, 11574821.
65. Wilcox CS. Regulation of renal blood flow by plasma chloride. J Clin Invest 1983, 71:726-735. 436923, 6826732, 10.1172/JCI110820.
66. Schnermann J, Ploth DW, Hermle M. Activation of tubulo-glomerular feedback by chloride transport. Pflugers Arch 1976, 362:229-240. 944430, 10.1007/BF00581175.
67. Eaton D, Pooler J. Vander's Renal Physiology 2009, New York: McGraw-Hill Medical, 7.
68. Bullivant EMA, Wilcox CS, Welch WJ. Intrarenal vasoconstriction during hyperchloraemia: role of thromboxane. Am J Physiol 1989, 256:152-157.
69. Quilley CP, Lin YS, McGiff JC. Chloride anion concentration as a determinant of renal vascular responsiveness to vasoconstrictor agents. Br J Pharmacol 1993, 108:106-110. 1907694, 8428200.
70. Williams EL, Hildebrand KL, McCormick SA, Bedel MJ. The effect of intravenous lactated Ringer's solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. Anesth Analg 1999, 88:999-1003. 10.1097/00000539-199905000-00006, 10320158.
71. Boldt J, Suttner S, Brosch C, Lehmann A, Rohm K, Mengistu A. The influence of a balanced volume replacement concept on inflammation, endothelial activation, and kidney integrity in elderly cardiac surgery patients. Intensive Care Med 2009, 35:462-470. 10.1007/s00134-008-1287-1, 18807007.
72. O'Malley CMN, Frumento RJ, Bennett-Guerrero E. Intravenous fluid therapy in renal transplant recipients: results of a U.S. survey. Transplant Proc 2002, 34:3142-3145. 10.1016/S0041-1345(02)03593-5, 12493402.
73. O'Malley CMN, Frumento RJ, Hardy MA, Benvenisty AI, Brentjens TE, Mercer JS, Bennett-Guerrero E. A randomized, double-blind comparison of lactated Ringer's solution and 0.9% NaCl during renal transplantation. Anesth Analg 2005, 100:1518-1524. 10.1213/01.ANE.0000150939.28904.81, 15845718.
74. Mythen MG, Hamilton MA. Hyperchloremic metabolic acidosis: is it clinically relevant?. Transfus Altern Transfus Med 2001, 4:15-19.
75. Tournadre JP, Allaouchiche B, Malbert CH, Chassard D. Metabolic acidosis and respiratory acidosis impair gastro-pyloric motility in anesthetized pigs. Anesth Analg 2000, 90:74-79. 10.1097/00000539-200001000-00018, 10624982.
76. Traverso LW, Lee WP, Langford MJ. Fluid resuscitation after an otherwise fatal hemorrhage: I. Crystalloid solutions. J Trauma 1986, 26:168-175. 10.1097/00005373-198602000-00014, 3080602.
77. Healey MA, Davis R, Liu FC, Loomis WH, Hoyt DB. Lactated Ringer's is superior to normal saline in a model of massive hemorrhage and resuscitation. J Trauma 1998, 45:894-899. 10.1097/00005373-199811000-00010, 9820700.
78. Ho AM-H, Karmakar KM, Contardi LH, Ng SW, Hewson JR. Excessive use of normal saline in managing traumatized patients in shock: a preventable contributor to acidosis. Trauma 2001, 51:173-177.
79. Gan TJ, Bennett-Guerrero E, Phillips-Bute B, Wakeling H, Moskowitz DM, Olufolabi Y, Konstadt SN, Bradford C, Glass PSA, Machin SJ, Mythen MG, . Hextend® Study Group Hextend®, a physiologically balanced plasma expander for large volume use in major surgery: a randomized phase III clinical trial. Anesth Analg 1999, 88:992-998. 10.1097/00000539-199905000-00005, 10320157, Hextend® Study Group.
80. Martin G, Bennett-Guererro E, Wakeling H, Mythen MG, El-Moalem H, Robertson K, Kucmeroski D, Gan TJ. A prospective, randomized comparison of thromboelastographic coagulation profile in patients receiving lactated Ringer's solution, 6% hetastarch in a balanced-saline vehicle, or 6% hetastarch in saline during major surgery. J Cardiothorac Vasc Anesth 2002, 16:441-446. 10.1053/jcan.2002.125146, 12154422.
81. Roche AM, James MFM, Grocott MPW, Mythen MG. Coagulation effects of in vitro serial haemodilution with a balanced electrolyte hetastarch solution compared with a saline-based hetastarch solution and lactated Ringer's solution. Anaesthesia 2002, 57:950-955. 10.1046/j.1365-2044.2002.02707.x, 12358952.
82. Roche AM, James MFM, Bennett-Guerrero E, Mythen MG. A head-to-head comparison of the in vitro coagulation effects of saline-based and balanced electrolyte crystalloid and colloid intravenous fluids. Anesth Analg 2006, 102:1274-1279. 10.1213/01.ane.0000197694.48429.94, 16551936.
83. Boldt J, Wolf M, Mengistu A. A new plasma-adapted hydroxyethylstarch preparation: in vitro coagulation studies using thromboelastography and whole blood aggregometry. Anesth Analg 2007, 104:425-430. 10.1213/01.ane.0000253484.19070.87, 17242103.